Hologic Q3 Revenues Grow 10 Percent; Firm Increases 2015 Revenue, EPS Guidance | GenomeWeb

NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that revenues for its fiscal third quarter were up 10 percent year over year. 

For the three months ended June 27, the firm posted total revenues of $693.9 million, up from $632.6 million in Q3 2014, and easily beat the consensus Wall Street estimate of $654 million. On a constant currency basis, revenues grew 12 percent year over year. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.